CRO News
Biofidelity and CellCarta Partner to Bring Aspyre Lung to Global Clinical Trials
Biofidelity, a company specialising in innovative genomic solutions, has partnered with CellCarta, a global contract research organisation (CRO), to integrate the Aspyre Lung platform into clinical trials worldwide. The partnership seeks to enhance the detection of NSCLC biomarkers, expediting clinical
10 January 2025
Stay ahead of trends and best practices
